The Effects of Trazodone on Sleep Apnea Severity
NCT01817907 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2017-02-24
Summary
In Obstructive sleep apnea (OSA), the upper airway closes over and over again during sleep. This leads to disrupted sleep (waking up during the night), daytime sleepiness, and an increased risk for developing high blood pressure. Currently, the best treatment for obstructive sleep apnea is sleeping with a mask that continuously blows air into the nose (i.e. Continuous positive airway pressure \[CPAP\] treatment). While CPAP treatment stops the upper airway from closing in most people, many people have difficulty sleeping with the mask in place and therefore do not use the CPAP treatment. This research study is being conducted to learn whether using a sedative will improve OSA severity by altering some of the traits that are responsible for the disorder.
Conditions
- Sleep Apnea, Obstructive
Interventions
- DRUG
-
Placebo pill
Subjects will receive a sugar pill during the placebo arm
- DRUG
-
Trazodone
Subjects will receive trazodone during one of their treatment arm studies
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Brigham and Women's Hospital
lead OTHER
Principal Investigators
-
David A Wellman, MD, PhD · Brigham and Women's Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2014-04-30
- Completion
- 2014-12-31
Countries
- United States
Study Locations
More Related Trials
-
Acetazolamide for Obstructive Sleep Apnea to Improve Heart Health
NCT05616260 ·Status: COMPLETED ·Phase: PHASE2
-
Acetazolamide as a Means to Mitigate Falling Ventilatory Drive and Drive-dependent OSA
NCT06091085 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea
NCT06295562 ·Status: COMPLETED ·Phase: PHASE4
-
Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep Apnea
NCT03892772 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment
NCT07210606 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Impact of Smoking, Benzodiazepine (BZD) Use and Obesity on Severe Obstructive Sleep Apnea (sOSA)
NCT02539264 ·Status: COMPLETED
-
Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep Apnea
NCT02387710 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing
NCT04611750 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Suboptimal CPAP Therapy on Symptoms of Obstructive Sleep Apnoea
NCT02781740 ·Status: COMPLETED ·Phase: NA
-
Atomoxetine and Oxybutynin in Obstructive Sleep Apnea
NCT02908529 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Trans Nasal Insufflation for the Treatment of Snoring
NCT00832026 ·Status: COMPLETED
-
Antihypertensive Effect of Continuous Positive Airway Pressure in Resistant Hypertensive Patients With Sleep Apnea
NCT00929175 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)
NCT01028534 ·Status: COMPLETED ·Phase: NA
-
Patient-centered and Neurocognitive Outcomes With Acetazolamide for Sleep Apnea
NCT05804084 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Self-Management on Improving Sleep Apnea Outcomes
NCT00310310 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Desipramine on Genioglossus Muscle Activity in Healthy Adults Study A
NCT02428478 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of CPAP on Diet, Physical Activity, and Cardiovascular Risk
NCT01944020 ·Status: COMPLETED ·Phase: NA
-
The Role of the Nose in Snoring and Sleep Apnea
NCT03072173 ·Status: UNKNOWN ·Phase: NA
-
Cognitive Benefits of Treating Sleep Apnea in Parkinson's Disease
NCT00492115 ·Status: COMPLETED ·Phase: NA
-
The Roles of Prostanoids in Patients With Sleep Apnea Syndrome
NCT01015872 ·Status: COMPLETED ·Phase: NA
-
Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic
NCT02699125 ·Status: COMPLETED ·Phase: PHASE4
-
Time Restricted Eating in Sleep Apnea
NCT06047496 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Remifentanil in Adults With OSA
NCT02898792 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
DAW1033B2 in Obstructive Sleep Apnea
NCT03426631 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea
NCT00211614 ·Status: WITHDRAWN ·Phase: NA